The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice
AbstractObesity and diabetes are major causes of morbidity and mortality globally. The current study builds upon our previous association studies highlighting that A Disintegrin And Metalloproteinase 28 (ADAM28) appears to be implicated in the pathogenesis of obesity and type 2 diabetes in humans. Our novel study characterised the expression of ADAM28 in mice with the metabolic syndrome and used molecular inhibition approaches to investigate the functional role of ADAM28 in the pathogenesis of high fat diet-induced obesity. We identified that ADAM28 mRNA and protein expression was markedly increased in the livers of mice with the metabolic syndrome. In addition, noradrenaline, the major neurotransmitter of the sympathetic nervous system, results in elevated Adam28 mRNA expression in human monocytes. Downregulation of ADAM28 with siRNA technology resulted in a lack of weight gain, promotion of insulin sensitivity/glucose tolerance and decreased liver tumour necrosis factor-α (TNF-α) levels in our diet-induced obesity mouse model as well as reduced blood urea nitrogen, alkaline phosphatase and aspartate aminotransferase. In addition, we show that ADAM28 knock-out mice also displayed reduced body weight, elevated high density lipoprotein cholesterol levels, and reductions in blood urea nitrogen, alkaline phosphatase, and aspartate aminotransferase. The results of this study provide important insights into the pathogenic role of the metalloproteinase ADAM28 in the metabolic syndrome and suggests that downregulation of ADAM28 may be a potential therapeutic strategy in the metabolic syndrome. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 63 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Herat, L.; Rudnicka, C.; Okada, Y.; Mochizuki, S.; Schlaich, M.; Matthews, V. The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice. Int. J. Mol. Sci. 2017, 18, 884.
Herat L, Rudnicka C, Okada Y, Mochizuki S, Schlaich M, Matthews V. The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice. International Journal of Molecular Sciences. 2017; 18(4):884.Chicago/Turabian Style
Herat, Lakshini; Rudnicka, Caroline; Okada, Yasunori; Mochizuki, Satsuki; Schlaich, Markus; Matthews, Vance. 2017. "The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice." Int. J. Mol. Sci. 18, no. 4: 884.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.